Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

J. Allen Overby

Member

Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX

J. Allen Overby

Member

Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX
Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX

Allen Overby has counseled some of the nation's most influential companies with respect to mergers and acquisitions, corporate governance, public company disclosure obligations, and a wide range of securities regulation matters. Allen's practice focuses primarily on public companies and middle market M&A transactions between $50 million and $1 billion, with an emphasis on cross border mergers and acquisitions and other strategic transactions.

Allen has been recognized by Chambers USA and is "described by sources as a 'tenacious negotiator' and a practitioner who 'sees the big picture.' Additionally, clients highlight his astute commercial awareness and praise him for bringing a business perspective to transactions. His practice offers considerable experience in M&A, private equity and corporate governance matters." (from Chambers USA 2018).

Allen Overby has counseled some of the nation's most influential companies with respect to mergers and acquisitions, corporate governance, public company disclosure obligations, and a wide range of securities regulation matters. Allen's practice focuses primarily on public companies and middle market M&A transactions between $50 million and $1 billion, with an emphasis on cross border mergers and acquisitions and other strategic transactions.

Allen has been recognized by Chambers USA and is "described by sources as a 'tenacious negotiator' and a practitioner who 'sees the big picture.' Additionally, clients highlight his astute commercial awareness and praise him for bringing a business perspective to transactions. His practice offers considerable experience in M&A, private equity and corporate governance matters." (from Chambers USA 2018). Allen's practice involves:

  • Mergers & Acquisitions/Cross-Border & Domestic – Representing public and private companies in connection with merger and acquisition transactions, and financing transactions (including offerings of debt and equity securities); Representing companies based in the U.S. and abroad in connection with cross-border mergers and acquisitions and strategic investments.
  • Corporate Governance & Public Company Disclosure – Advising public companies on corporate governance, fiduciary duties, securities law compliance, public company disclosure obligations, executive compensation and takeover defense matters.
  • Securities Regulation – Advising as independent counsel for regulatory and compliance matters. Representative matters include the Regulatory Audit of the New York Stock Exchange from 2005 to 2013 and serving as audit committee disclosure counsel to an NYSE listed global financial services company. As a former member of the staff of the Division of Enforcement at the U.S. Securities and Exchange Commission (SEC) in Washington, D.C., Allen also works closely with audit and special committees regarding a wide variety of issues.

Allen is a past member of the firm's Executive Committee and the past chair of the Corporate & Securities Practice Group.

In addition to his law practice, Allen served as an adjunct professor at the Vanderbilt University Law School where he taught courses on mergers and acquisitions and the federal securities laws.

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA)

Lex Mundi — Cross Border Transactions Group

News

View More

Representative Experience

View More

Publications

View More

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Corporate M&A (2008-2009, 2013-2018)

Best Lawyers in America® — Corporate Governance Law; Corporate Law; Leveraged Buyouts and Private Equity Law; Mergers and Acquisitions Law; Securities Regulation (2007-2018)

Best Lawyers in America®  — Nashville Securities Regulation "Lawyer of the Year" (2018, 2014); Nashville Leveraged Buyouts and Private Equity Law "Lawyer of the Year"(2017); Nashville Mergers and Acquisitions Law "Lawyer of the Year" (2012)

The Legal 500 United States 2016 — M&A/Corporate and Commercial for M&A: Middle-Market (sub-$500m)

Lawdragon "New Stars"

Mid-South Super Lawyers (2007-2008)

Mississippi Law Journal — Editorial Board Member (1987)

U.S. Securities and Exchange Commission — Former Senior Counsel

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.